325 related articles for article (PubMed ID: 9648835)
1. Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.
Kruszynska YT; Mulford MI; Baloga J; Yu JG; Olefsky JM
Diabetes; 1998 Jul; 47(7):1107-13. PubMed ID: 9648835
[TBL] [Abstract][Full Text] [Related]
2. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
[TBL] [Abstract][Full Text] [Related]
3. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.
Vestergaard H; Bjørbaek C; Hansen T; Larsen FS; Granner DK; Pedersen O
J Clin Invest; 1995 Dec; 96(6):2639-45. PubMed ID: 8675629
[TBL] [Abstract][Full Text] [Related]
4. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
[TBL] [Abstract][Full Text] [Related]
5. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM.
Simoneau JA; Kelley DE
J Appl Physiol (1985); 1997 Jul; 83(1):166-71. PubMed ID: 9216960
[TBL] [Abstract][Full Text] [Related]
6. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
Vestergaard H
Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
[TBL] [Abstract][Full Text] [Related]
7. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
Kelley DE; Mokan M; Mandarino LJ
Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
[TBL] [Abstract][Full Text] [Related]
8. Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM.
Yki-Järvinen H; Daniels MC; Virkamäki A; Mäkimattila S; DeFronzo RA; McClain D
Diabetes; 1996 Mar; 45(3):302-7. PubMed ID: 8593934
[TBL] [Abstract][Full Text] [Related]
9. Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment.
Kudolo GB; Bressler P; DeFronzo RA
J Lipid Mediat Cell Signal; 1997 Nov; 17(2):97-113. PubMed ID: 9459136
[TBL] [Abstract][Full Text] [Related]
10. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
[TBL] [Abstract][Full Text] [Related]
11. Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.
Christiansen E; Vestergaard H; Tibell A; Hother-Nielsen O; Holst JJ; Pedersen O; Madsbad S
Diabetes; 1996 Sep; 45(9):1267-75. PubMed ID: 8772733
[TBL] [Abstract][Full Text] [Related]
12. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed mice: studies in mice with a 50% reduction of hexokinase II.
Fueger PT; Lee-Young RS; Shearer J; Bracy DP; Heikkinen S; Laakso M; Rottman JN; Wasserman DH
Diabetes; 2007 Oct; 56(10):2476-84. PubMed ID: 17639019
[TBL] [Abstract][Full Text] [Related]
14. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus.
Kruszynska YT; Mukherjee R; Jow L; Dana S; Paterniti JR; Olefsky JM
J Clin Invest; 1998 Feb; 101(3):543-8. PubMed ID: 9449686
[TBL] [Abstract][Full Text] [Related]
16. Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin.
Damsbo P; Hermann LS; Vaag A; Hother-Nielsen O; Beck-Nielsen H
Diabetes Care; 1998 Sep; 21(9):1489-94. PubMed ID: 9727896
[TBL] [Abstract][Full Text] [Related]
17. Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM.
Klein HH; Vestergaard H; Kotzke G; Pedersen O
Diabetes; 1995 Nov; 44(11):1310-7. PubMed ID: 7589829
[TBL] [Abstract][Full Text] [Related]
18. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
[TBL] [Abstract][Full Text] [Related]
19. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM.
Bonadonna RC; Del Prato S; Bonora E; Saccomani MP; Gulli G; Natali A; Frascerra S; Pecori N; Ferrannini E; Bier D; Cobelli C; DeFronzo RA
Diabetes; 1996 Jul; 45(7):915-25. PubMed ID: 8666143
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of the kinetic defect in insulin action in obesity and NIDDM.
Nolan JJ; Ludvik B; Baloga J; Reichart D; Olefsky JM
Diabetes; 1997 Jun; 46(6):994-1000. PubMed ID: 9166671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]